This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TearLab Corporation To Release Q2-10 Financial Results On August 12, 2010

SAN DIEGO, Aug. 3, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its financial results for the second quarter and six months ended June 30, 2010 before the market opens on Thursday, August 12, 2010.

OccuLogix is pleased to invite all interested parties to participate in a conference call during which the financial results will be discussed. The call will be held on August 12, at 8:30a.m. Eastern Daylight Savings Time at 877-303-6310 (within the United States and Canada).

The call will be broadcast live and archived on the company's web-site at www.tearlab.com under the "webcasts" link in the investor Relations section.



 Date:  August 12, 2010
 Time:  8:30 AM ET

Listen via Internet: http://www.tearlab.com/us/shareholder.htm/

Schedule this webcast into MS-Outlook calendar (click open when prompted):

http://apps.shareholder.com/PNWOutlook/t.aspx?m=43708&k=0016EDAD



 Telephone:  877-303-6310

For those wishing to listen to a recording of the call via telephone, a replay will be made available as soon as possible after the conclusion of the live call and will remain posted for a period of seven days. To listen to the recording, simply telephone (Toll free) 800-642-1687 or Toll 706-645-9291 and enter reservation #92168732 when prompted.

About OccuLogix, Inc. dba TearLab Corporation

OccuLogix dba TearLab Corporation ( www.tearlab.com) develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'. TearLab received the CE Mark for its TearLab(TM) Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 20 countries including the US.

Forward-Looking Statements

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
TLB $0.00 0.00%
TEAR $2.55 0.39%
AAPL $126.63 -1.60%
FB $77.58 -1.60%
GOOG $533.68 -1.30%

Markets

DOW 18,012.85 -57.55 -0.32%
S&P 500 2,101.44 -13.05 -0.62%
NASDAQ 4,960.9980 -55.9310 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs